# Profoundd archive — Epstein Files
# Bates number: EFTA02669160
# Title:        From: Kathy Ruemmler
# Dataset:      11
# Pages:        2
# Tags:         epstein, doj, dataset-11
# Source PDF:   https://profoundd.com/epstein-docs/EFTA02669160/download
# Doc viewer:   https://profoundd.com/epstein-docs/EFTA02669160
#
# Text below is what Profoundd has extracted from the source PDF.
# 'ocr-enriched' tag means OCR was applied to scan-only pages.
# Image descriptions are AI-generated factual captions (llava:13b).
#----------------------------------------------------------------------

=== SUMMARY ===
From: Kathy Ruemmler Sent: Tuesday, November 22, 2016 1:32 PM To: Jeffrey E. Subject: Fwd: Begin forwarded=message: From: =ate: November 22, 2016 at 8:30:34 AM EST To: =/blockquote> The National Law Journal Mylan Won't Testify at EpiP=n Hearing, Drawing Chuck Grassley's Ire<http://www.nationallawjourna=.com/id=1202772942932/Mylan-Wont-Testify-at-EpiPen-Hearing-Drawing-Chuck- =rassleys-lre?slreturn=20161022074622 <http://www.nationalla=journal.com/id=1202772942932/Mylan-Wont-Testify- at-EpiPen-He


=== EXTRACTED TEXT ===
From: Kathy Ruemmler 
Sent: Tuesday, November 22, 2016 1:32 PM 
To: Jeffrey E. 
Subject: Fwd: 
Begin forwarded=message: 
From: 
=ate: November 22, 2016 at 8:30:34 AM EST 
To: 
=/blockquote> 
The National Law Journal 
Mylan Won't Testify at EpiP=n Hearing, Drawing Chuck Grassley's 
Ire<http://www.nationallawjourna=.com/id=1202772942932/Mylan-Wont-Testify-at-EpiPen-Hearing-Drawing-Chuck-
=rassleys-lre?slreturn=20161022074622 <http://www.nationalla=journal.com/id=1202772942932/Mylan-Wont-Testify-
at-EpiPen-Hearing-Drawing=Chuck-Grassleys-lre?slreturn=20161022074622» 
November 21,=2016 
Obama administration officials and Mylan N.V. are decl=ning to send representatives to testify at a 
Senate Judiciary Committee hea=ing this month that would explore the government's $465 million set=lement with the 
pharmaceutical company over its alleged misclassification o= the life-saving device EpiPen for purposes of Medicaid 
rebates. 
=span>Sen. Chuck Grassley, R-Iowa, chairman of Senate Judiciary, has questio=ed the 
fairness<http://www.law.comMtes/almstaff/2016/10/11/mylans-465m-epipen-settlement-unlikely-to-end-scru=iny/ 
<http://www.law.com/sites/almstaff/2016/10/11/=ylans-465m-epipen-settlement-unlikely-to-end-scrutiny/» of the 
deal that Mylan said it had reached in October with therU.S. Justice Department and regulatory agencies. The 
settlement, which Myla= announced in a news release<http://newsroom.mylan.com/2016-10-07-Mylan-Agrees-to-
Settlem=nt-on-Medicaid-Rebate-Classification-for-EpiPen-Auto-Injector chttp://newsroom.mylan.com/2016-1=-07-
Mylan-Agrees-to-Settlement-on-Medicaid-Rebate-Classification-for-EpiPen=Auto-Injector», came=amid the public 
outcry over Mylan's decision to increase the price o= its epinephrine auto-injector EpiPen. 
The Justice Departme=t and Centers for Medicaid and Medicare Services haven't commented o= the 
settlement. Mylan didn't admit any wrongdoing. 
Grassley0=99s full statement: 
The Obama administration is dodging acc=untability for an expensive problem, and now a company is 
following its bad=example. Taxpayers have paid and based on reports, continue to pay, hundred= of millions of dollars 
more for the EpiPen than they have to pay. This hap=ened because either the agencies in charge dropped the ball, the 
company ga=ed the system, or both. Ironically, the company was eager to talk about thi= problem a few weeks ago in a 
press release to investors but not before the=United States Senate. It's a shame government agencies and the comp=ny 
EFTA_R1_01921650 
EFTA02669160
are ducking accountability under a voluntary process. One way or another= I intend to get answers for patients and 
taxpayers. 
Mylan i= represented by Kathryn Ruemmler, a Latham & Watkins partner who is glo=al co-chairwoman 
of its white-collar defense practice and a former White Ho=se 
counsel<http://www.nationallawjournal.com/legaltimes/id=12026565765=8 
<http://www.nationallawjournalcom/legaltimes/id==202656576548» in the Obama administration. 
Ruemmler said in a 
l=tter<http://www.g=assley.senate.gov/sites/default/files/constituents/Mylan%20letter%20declini=g%20to%20testify% 
20111816.pdf 
<http://www.grassley.senate.gov/sites/default/files/const=tuents/Mylan%20letter%20declining%20to%20testify%2011 
1816.pdf» to Grassley last week that the compan= would decline to testify at the hearing. 
"We under=tand that representatives of those government agencies have confirmed to th= committee 
that they are not able to send a witness to testify or provide f=rther information about this matter while it is pending," 
Ruemmler w=ote. "Given the stated focus of the proposed hearing, the fact that=it involves a pending matter, and that 
the government agencies in question w=ll not be able to send a witness to testify or provide further information,=Mylan 
respectfully declines to invitation to testify." 
This email may contain material t=at is confidential, privileged and/or attorney work product for the sole 
us= of the intended recipient. Any review, reliance or distribution by o=hers or forwarding without express permission is 
strictly prohibited. =lf you are not the intended recipient, please contact the sender and delete=all copies. 
Latham & Watkins LLP 
2 
EFTA_R1_01921651 
EFTA02669161